Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
03/1995
03/24/1995CA2132579A1 Adhesion receptor antagonists iii
03/23/1995WO1995007995A2 Adeno-associated viral (aav) liposomes and methods related thereto
03/23/1995WO1995007994A2 Recombinant alphavirus vectors
03/23/1995WO1995007981A1 Grb3-3 gene, variants and uses thereof
03/23/1995WO1995007934A2 Il8 inhibitors
03/23/1995WO1995007920A1 Nucleotide analogs
03/23/1995WO1995007919A1 Method for dosing therapeutic compounds
03/23/1995WO1995007917A1 5-(1-fluoro-vinyl)-1h-pyrimidine-2,4-dione derivatives useful as antineoplastic agents
03/23/1995WO1995007902A1 Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof
03/23/1995WO1995007718A2 Purine nucleoside phosphorylase gene therapy for human malignancy
03/23/1995WO1995007706A1 The semaphorin gene family
03/23/1995WO1995007700A1 Method for protection against genotoxic mutagenesis
03/23/1995WO1995007698A1 Trans platinum(iv) complexes
03/23/1995WO1995004552A3 Radiometal complexes that localise in hypoxic tissue
03/23/1995WO1995004142A3 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression
03/23/1995CA2171868A1 Method for dosing therapeutic compounds
03/23/1995CA2171318A1 Adeno-associated viral (aav) liposomes and methods related thereto
03/23/1995CA2169938A1 Grb3-3 gene; variants and uses thereof
03/22/1995EP0644265A1 Antitumor agent
03/22/1995EP0644197A1 Peptidic phosphinyloxymethyl ketones as interleukin-1beta-converting enzyme inhibitors
03/22/1995EP0644181A1 Amino acid derivative and use thereof
03/22/1995EP0643973A1 Use of human interferon-beta for the preparation of pharmaceutical compositions for treating Chronic Myeloid Leukemia
03/22/1995EP0643972A2 Use of recombinant colony stimulating factor-1 for the preparation of a medicament for cytomegalovirus infections and leukopenia
03/22/1995EP0643959A1 Use of 13-transretinoic acid esters for the treatment of skin cancer and photoaging
03/22/1995EP0643726A1 PEPTIDES OF HUMAN p53 PROTEIN FOR USE IN HUMAN T CELL RESPONSE INDUCING COMPOSITIONS, AND HUMAN p53 PROTEIN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES
03/22/1995EP0643693A1 Reversal of multi-drug resistance by triphenyl-azacycloalkane derivatives
03/22/1995EP0643690A1 Desferrioxamine-b salts and their use as orally effective iron chelators
03/22/1995EP0643583A1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy
03/22/1995EP0527803B1 Composition for macrophage activation
03/22/1995EP0301087B1 Peptide
03/22/1995CN1100426A Lysosomal enzyme-cleavable antitumor drug conjugates
03/22/1995CN1100413A Urethanes and ureas that induce cytokine production
03/22/1995CN1100320A Dysphagia pills
03/21/1995US5399691 Antitumor agents
03/21/1995US5399590 Treatment of skin tumors, rheumatic diseases
03/21/1995US5399586 Treatment of mammals afflicted with tumors with compounds having RXR retinoid receptor agonist activity
03/21/1995US5399570 Aspartic acid derivatives, and their use for inhibiting platelete aggregation
03/21/1995US5399563 Benzylidenequinuclidinones
03/21/1995US5399561 Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydro-quinolinyl group having retinoid-like biological activity
03/21/1995US5399485 Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis caused by Rochalimaea henselae
03/21/1995US5399363 IV administration for insoluble medicaments
03/21/1995US5399341 Use of cytokin-containing aerosols and the cytokin-containing aerosols
03/21/1995CA1334826C Pharmaceutical compositions comprising benzylidene-and cinnamylidene-malononitrile derivatives for the inhibition of proliferative processes in mammalian cells, certain such novelcompounds and their preparation
03/17/1995CA2131681A1 Antitumor agent
03/16/1995WO1995007462A1 Diagnostic, prognostic, and therapeutic methods for solid non-lymphoid tumors and their metastases
03/16/1995WO1995007364A1 Nucleic acid ligands and improved methods for producing the same
03/16/1995WO1995007348A1 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations
03/16/1995WO1995007302A1 Ganglioside gm3 derivative having fluorinated ceramide moiety
03/16/1995WO1995007276A1 Bicyclic heterocyclic sulfonamide and sulfonic ester derivatives
03/16/1995WO1995007089A1 Immunomodulating compositions from bile
03/16/1995WO1995003328A3 Melanoma-inhibiting protein
03/16/1995WO1995002420A3 Prodrugs of protein tyrosine kinase inhibitors
03/16/1995WO1995002051A3 A pharmaceutical composition comprising antisense-nucleic acid for prevention and/or treatment of neuronal injury, degeneration and cell death and for the treatment of neoplasms
03/16/1995WO1995000643A3 Human cell adhesion protein aamp-1 and uses thereof
03/16/1995CA2171112A1 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations
03/16/1995CA2170623A1 Diagnostic, prognostic, and therapeutic methods for solid non-lymphoid tumors and their metastases
03/16/1995CA2169536A1 Nucleic acid ligands and improved methods for producing the same
03/15/1995EP0643077A1 Monoclonal antibody against B70 molecule
03/15/1995EP0643069A1 2'-deoxy-2'-fluorocoformycin and stereoisomers thereof
03/15/1995EP0643058A1 Crystals of an antimicrobial compound
03/15/1995EP0642799A1 Improved prodrugs for enzyme mediated activation
03/15/1995EP0642792A1 Stabilized solutions of platinum (II) antitumor agents
03/15/1995EP0642591A1 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
03/15/1995EP0642589A1 Method and reagent for inhibiting viral replication
03/15/1995EP0642586A1 CULTURED $i(TAXUS) TISSUES AS A SOURCE OF TAXOL, RELATED TAXANES AND OTHER NOVEL ANTI-TUMOR/ANTI-VIRAL COMPOUNDS
03/15/1995EP0642584A1 Nucleic acid corresponding to a gene of chromosome 22 involved in recurrent chromosomal translocations associated with the development of cancerous tumors
03/15/1995EP0642530A1 Derivatives of dolastatin
03/15/1995EP0642529A1 11-g(b)-SUBSTITUTED 14,17-ETHANOESTRATRIENES, PROCESS FOR PREPARING THESE COMPOUNDS AND THEIR USE FOR PREPARING MEDICAMENTS.
03/15/1995EP0642513A1 Indolocarbazole imides and their use
03/15/1995EP0642509A1 Novel potent inducers of terminal differentiation and methods of use thereof
03/15/1995EP0642503A1 10-desacetoxytaxol derivatives
03/15/1995EP0642499A1 Retinoids and their use in treating skin diseases and leukemia
03/15/1995EP0642357A1 Radiolabelled peptide compounds
03/15/1995EP0642351A1 New pharmaceutical uses of krill enzymes
03/15/1995EP0642347A1 Use of 2-halo adenine derivatives as therapeutic agents against chronic myelogenous leukemia
03/15/1995EP0642345A1 Halichondrins and related compounds
03/15/1995EP0642343A1 Treatment of cancers
03/15/1995EP0642341A1 Use of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme a reductase as a modality in cancer therapy
03/15/1995EP0535129B1 An anticoagulant preparation
03/15/1995EP0433393B1 Treatment of damaged bone marrow and dosage units therefor
03/15/1995EP0414741B1 Further improvements relating to drug delivery systems
03/15/1995EP0394333B1 Uses of sulphated sugars
03/14/1995US5397796 Inhibitors of platelet aggregation, metastasis of carcinoma cells and osteoclast binding to the bone surfaces
03/14/1995US5397787 Vinylene-azaindole derivatives
03/14/1995US5397784 Stable parenteral compositions of vinblastine or vincristine
03/14/1995CA1334760C N-(2'-aminophenyl)-benzamide-derivatives, process for their preparation and their use in the control of neoplastic diseases
03/14/1995CA1334759C N,n'-diaminocarbonylmethyl-n,n'-dicarboxymethyl-1,2- diaminoethane derivatives
03/14/1995CA1334757C Rhizoxin derivatives and their use as anti-tumor agents
03/14/1995CA1334754C 5-aryl-substituted-2,3-dihydro-imidazo¬1,2-a|furo and -thieno pyridines
03/09/1995WO1995006734A1 Cloning of a member of the serine-threonine-kinase family
03/09/1995WO1995006725A1 Immunoreactive peptide sequence from a 43 kd human cancer antigen
03/09/1995WO1995006688A1 Phthalocyanine photosensitizers for photodynamic therapy and methods for their synthesis and use
03/09/1995WO1995006661A1 MUTANTS OF THE Rb AND p53 GENES AND USES THEREOF
03/09/1995WO1995006486A1 Treatment of human tumors by genetic transformation of human tumor cells
03/09/1995WO1995006469A1 Benzazole compounds for use in therapy
03/09/1995WO1995006415A1 Senescent cell-derived inhibitors of dna synthesis
03/09/1995WO1995002613A3 Heparin derivatives having antimetastatic activity
03/09/1995WO1995001348A3 Imides as inhibitors of tnp alpha
03/09/1995DE3590020C2 1-Hydroxy-vitamin-D compounds which are unsaturated in the side chain
03/09/1995CA2170974A1 Phthalocyanine photosensitizers for photodynamic therapy and methods for their synthesis and use
1 ... 2098 2099 2100 2101 2102 2103 2104 2105 2106 2107 2108 2109 2110 2111 2112 2113 2114 2115 2116 2117 2118 ... 2211